Downstream Issues Still Beset Production
To Protect the Bottom Line, Biomanufacturers Invest in Downstream Purification Technology
GEN Roundup: No Detail Is Too Small in Bioprocess Scaleup
A Change in Scale Can Change Everything
Amid Election Clamor, Research Issues Surface
Sounds of Science Podcast
10 Takeover Targets of 2016
Which Biopharmas Do Wall Street Watchers View As Top Buyout Candidates?
For full access to this article login to GEN Select now.
Stem Cell Studies Go Forward Despite Some Opposition
Scientists in Academia Are Pushing Young Field Ahead with Diverse Range of Applications
- The field of stem cell research is progressing rapidly despite technical and policy challenges. In fact, the global stem cell market is estimated to reach $88.3 billion by 2014, with the U.S. holding 60% of the market, according to a 2009 report from Bharat Book Bureau. Although U.S. ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.